Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (521-530 of 706) with videos related to

Pageof 71
Sort By:
The Lancet. Diabetes & Endocrinology|October 25, 2025
Recent advances in research and care of familial hypercholesterolaemiaRaul D Santos, Samuel S Gidding, Mafalda Bourbon, et al.
Clinical Genetics|October 2, 2019
A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessmentKatrina L Ellis, Amanda J Hooper, Jing Pang, et al.
Atherosclerosis|July 2, 2018
Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaqueEsther Mm Ooi, Katrina L Ellis, P Hugh R Barrett, et al.
Heart, Lung & Circulation|August 10, 2024
Time Trends and Missed Opportunities in Lipoprotein(a) Testing Amongst Young Patients With ST-Elevation Myocardial Infarction in Western AustraliaCiaran Kelly, Nick S R Lan, Jane Phan, et al.
Journal of Lipid Research|April 25, 2002
Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath testDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Journal of Clinical Lipidology|June 23, 2022
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemiaMichael M Page, Katrina L Ellis, Dick C Chan, et al.
BMC Cardiovascular Disorders|January 20, 2021
Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in MalaysiaAhmad Baihaqi Azraii, Anis Safura Ramli, Zaliha Ismail, et al.
European Journal of Preventive Cardiology|October 4, 2025
External validation of the SAFEHEART risk-equation for predicting cardiovascular events in Australian patients with familial hypercholesterolaemiaMaría Elena Mansilla-Rodríguez, Manuel Jesús Romero-Jiménez, Jing Pang, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 27, 2015
Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetesRebecca Negrulj, Armin Mooranian, Nigel Chen-Tan, et al.
Vascular Health and Risk Management|December 2, 2025
Lipoprotein(a) and Its Role in Peripheral Arterial Disease: A Narrative ReviewBibombe Patrice Mwipatayi, James Evan Dodd, Amirul Hakim Ahmad Bazlee, et al.
Pageof 71

Showing results (521-530 of 706) with videos related to

Sort By:
Pageof 71
The Lancet. Diabetes & Endocrinology|October 25, 2025
Recent advances in research and care of familial hypercholesterolaemiaRaul D Santos, Samuel S Gidding, Mafalda Bourbon, et al.
Clinical Genetics|October 2, 2019
A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessmentKatrina L Ellis, Amanda J Hooper, Jing Pang, et al.
Atherosclerosis|July 2, 2018
Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaqueEsther Mm Ooi, Katrina L Ellis, P Hugh R Barrett, et al.
Heart, Lung & Circulation|August 10, 2024
Time Trends and Missed Opportunities in Lipoprotein(a) Testing Amongst Young Patients With ST-Elevation Myocardial Infarction in Western AustraliaCiaran Kelly, Nick S R Lan, Jane Phan, et al.
Journal of Lipid Research|April 25, 2002
Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath testDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Journal of Clinical Lipidology|June 23, 2022
A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemiaMichael M Page, Katrina L Ellis, Dick C Chan, et al.
BMC Cardiovascular Disorders|January 20, 2021
Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in MalaysiaAhmad Baihaqi Azraii, Anis Safura Ramli, Zaliha Ismail, et al.
European Journal of Preventive Cardiology|October 4, 2025
External validation of the SAFEHEART risk-equation for predicting cardiovascular events in Australian patients with familial hypercholesterolaemiaMaría Elena Mansilla-Rodríguez, Manuel Jesús Romero-Jiménez, Jing Pang, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 27, 2015
Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetesRebecca Negrulj, Armin Mooranian, Nigel Chen-Tan, et al.
Vascular Health and Risk Management|December 2, 2025
Lipoprotein(a) and Its Role in Peripheral Arterial Disease: A Narrative ReviewBibombe Patrice Mwipatayi, James Evan Dodd, Amirul Hakim Ahmad Bazlee, et al.
Pageof 71